Revelstoke Capital Partners has made a significant growth investment in ClareMedica Health Partners, a leader in value-based primary care for Medicare Advantage members in Florida, to expand its innovative healthcare services into new markets.

Information on the Target

ClareMedica Health Partners, LLC, based in Florida, specializes in providing value-based primary care specifically tailored for Medicare Advantage members. The company has established itself as a leader in this sector, focusing on high-quality, coordinated healthcare that aims to improve health outcomes for its patients. Under the leadership of CEO Roberto Palenzuela, ClareMedica is poised to expand its innovative BetterCare℠ model into new markets, further enhancing its service offerings and reach.

ClareMedica operates through a network of employed and affiliated physicians, delivering comprehensive healthcare services with a patient-centric approach. This unique positioning not only benefits patients but also aligns closely with the evolving dynamics of the healthcare industry, which increasingly supports value-based care models.

Industry Overview in Florida

The healthcare sector in Florida is undergoing a significant transformation driven by the adoption of value-based care models. As healthcare payers and providers shift away from traditional fee-for-service paradigm

View Source

Similar Deals

New Mountain Capital Smarter Technologies

2025

Growth Equity & Expansion Capital Healthcare Facilities & Services (NEC) United States of America
Unifeye Vision Partners Brooks Eye Associates

2025

Growth Equity & Expansion Capital Hospitals, Clinics & Primary Care Services United States of America
Advantage Capital Gravity Diagnostics

2025

Growth Equity & Expansion Capital Medical & Diagnostic Laboratories United States of America
Eir Partners Porter

2025

Growth Equity & Expansion Capital Home Healthcare Services United States of America
Ampersand Capital Partners Lexington Medical

2025

Growth Equity & Expansion Capital Medical Devices & Implants United States of America
Ampersand Capital Partners Gannet BioChem

2025

Growth Equity & Expansion Capital Biopharmaceuticals United States of America

Revelstoke Capital Partners

invested in

ClareMedica Health Partners, LLC

in 2022

in a Growth Equity & Expansion Capital deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert